Syed Qaiser Shah

5PUBLICATIONS
4CO-AUTHORS
Instruments and techniquesCancer therapy (excl. chemotherapy and radiation therapy)Satellite, space vehicle and missile design and testingMolecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 07, 2026
Preclinical targeted alpha therapy of B7-H3-positive tumors using [225Ac]Ac-Macropa-PEG2-enoblituzumab via EDC/NHS-mediated conjugation.

|Jul 15, 2026
FcRn-Targeted Alpha Therapy Using [225Ac]Ac-Macropa-Rozanolixizumab Enables Potent Antitumor Activity.

|May 07, 2026
IGF2R-Targeted Alpha Therapy of Osteosarcoma Enabled by Conjugated [225Ac]Ac-Macropa-PEG4-IF3.

|Feb 10, 2026
Preclinical Evaluation of [225Ac]Ac-Sibrotuzumab Employing a PEG4-Macropa Site-Specific Chelation Strategy for Targeted Ablation of Cancer-Associated Fibroblasts in Desmoplastic Tumors.

Syed Qaiser Shah, Ralph Santos-Oliveira, Madeeha Shabnam

|Oct 07, 2025
Synthesis and Preclinical Evaluation of 99ᵐTc-HYNIC-Finasteride: A Novel SPECT Radiotracer Targeting 5α-Reductase in Prostate Cancer.

Saba Shirin, Syed Qaiser Shah, Ralph Santos-Oliveira

Pageof 1

Frequent Collaborators

1 joint publications

Ralph Santos-Oliveira

1 joint publications

Derya Ilem-Ozdemir

1 joint publications

Madeeha Shabnam

1 joint publications

Ralph Santos-Oliveira